You are already subscribed with the entered email address.

Your e-mail address is known to us, but you are inactive in the receipt list. We have sent you a confirmation email with an activation link to reactivate your account and receive the newsletter in the future.

You have signed up for the newsletter and receive a confirmation email on your entered email address containing an activation link that you must follow to confirm your application.
It may take a few minutes before you receive this email.

Slide background

Date: 24-02-2022

Basic Pharma sells its stake in Geleen-based Pharmalot Compounding

Basic Pharma is selling its 50% stake in Pharmalot Compounding to Ace Compounding, a subsidiary of the Zeewolde-based company Ace Holding. This merger will make Ace Holding a larger and stronger player in the pharmacy preparation market with a large sales channel.

Pharmalot is the wholesale compounding pharmacy that Basic Pharma and Mosadex jointly set up and further developed into a highly successful formula. Pharmalot supplies a niche range of compounded drugs to 800 pharmacies and dispensing physicians across the Netherlands.

The sale of Pharmalot Compounding will enable Basic Pharma to further expand its core activities.

Strategic collaboration with Ace
The sale to Ace will allow Basic Pharma to intensify its focus on growing its core activities relating to the development and manufacture of medicines and the provision of services to the pharmaceutical industry. 'In addition, Basic Pharma and Ace intend to work together on quality control, product development and manufacturing of medicines as both firms possess a great deal of complementary knowledge in these areas,' explains Bob Kool, CEO of Basic Pharma.

Synergy in the pharmacy preparation sector
Ace's objective for the takeover of Pharmalot is to strengthen its market position.
Basic Pharma and Mosadex, the current shareholders of Pharmalot, are convinced that concentrating pharmacy preparation activities within Ace will help guarantee continuity and optimise opportunities to develop these activities.

Basic Pharma
Basic Pharma is an independent group of pharmaceutical firms focusing on the development, licensing, manufacturing and commercialisation of pharmaceutical and biopharmaceutical products (including clinical trial medications). It also provides a wide range of services to the pharmaceutical industry such as quality control, regulatory services, pharmacovigilance services, quality services and project management/support during the product development process.

Ace Compounding
Ace Compounding is a joint venture owned by Ace Holding, the parent company of Ace Pharmaceuticals and Mosadex Groep. For the past 30 years, the Zeewolde-based firm Ace has been delivering tailored pharmaceuticals for specific patient needs: registered medications, clinical trial medications and prescription medications. Since 2020, the firm has also provided ad hoc compounded medications from stock as well as ad hoc compounded medications.


Mosadex Groep
Via its twelve subsidiaries, full-service pharmaceutical firm Mosadex Groep has been serving over 800 independent public pharmacies to facilitate optimal business operations, distribution of medications and medical aids, pharmaceutical treatment/self-treatment and digitisation. Its characteristically cooperative structure ensures Mosadex Groep and its subsidiaries are closely involved in the sector and know exactly what is going on in the market at all times.

Sign up for our newsletter
Sign up
Basic Pharma
Contact us via email or phone or come by our office!
phone+31 (0)88 255 40 10


icon

Burgemeester Lemmensstraat 352
P.O. Box 1124
6160 BC Geleen
The Netherlands

In the event of an urgent safety issue,
please contact us:

+31 (0)88 255 40 60

You can report any suspected adverse drug reactions / side effects of our medications by sending an email to: pv@interdos.nl

map

When using navigation systems. Use the address: Koestraat 1, 6167 RA, Geleen
Get directions

© 2022 | All rights reserved | Basic Pharma | Privacy Statement | Design and development www.advacom.nl